Inhibition of the mammalian target of rapamycin (mTOR) as a potential antiepileptogenic therapy: from tuberous sclerosis to common acquired epilepsies - A review of the evidence
mTOR inhibition shows antiepileptogenic effects in tuberous sclerosis mouse models and limited clinical data; evidence remains preclinical and not definitive.
Authors
- Deborah Iodice (ORCID: https://orcid.org/0009-0004-6095-5471)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-17
- DOI
- https://doi.org/10.5281/zenodo.24306485
- Primary Topic
- Tuberous Sclerosis Complex Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00